The Ritedose Corporation is a pharmaceutical company specializing in blow-fill-seal (BFS) manufacturing of small fill volume pharmaceutical unit dose sterile and non-sterile liquids. They focus on producing inhalation products, eye drops, eardrops, and unit dose oral liquids. Ritedose rigorously controls its supply chain and processes to ensure maximum risk mitigation and safe delivery systems for pharmaceutical products. With a 27-year track record, they have delivered over 10 billion doses since 2012 without interruption and maintain exceptional compliance with regulatory bodies like the FDA. Ritedose operates a 503B Outsourcing Facility that manufactures and delivers sterile, pre-filled syringe products for hospitals and healthcare facilities in the U.S.